mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.2 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.2 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |